PANACEABIO.NSPANACEABIO.NSNSE
Loading
Year-over-year net income growth rate
3Y CAGR
+76.5%/yr
Quarterly compound
Percentile
P87
Within normal range
vs 3Y Ago
5.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 128.59% |
| Q3 2025 | -443.70% |
| Q2 2025 | 314.29% |
| Q1 2025 | -141.81% |
| Q4 2024 | -5.83% |
| Q3 2024 | 130.38% |
| Q2 2024 | -850.09% |
| Q1 2024 | 27.06% |
| Q4 2023 | 72.50% |
| Q3 2023 | -175.50% |
| Q2 2023 | 190.24% |
| Q1 2023 | -162.81% |
| Q4 2022 | 23.38% |
| Q3 2022 | 127.97% |
| Q2 2022 | -104.54% |
| Q1 2022 | 2615.13% |
| Q4 2021 | 7.19% |
| Q3 2021 | 7.57% |
| Q2 2021 | -5.84% |
| Q1 2021 | -35.30% |
| Q4 2020 | -107.19% |
| Q3 2020 | 43.36% |
| Q2 2020 | 51.02% |
| Q1 2020 | -226.82% |
| Q4 2019 | 71.57% |
| Q3 2019 | -165.30% |
| Q2 2019 | -115.20% |
| Q1 2019 | 1266.42% |
| Q4 2018 | 83.57% |
| Q3 2018 | -175.10% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q3 2015 | 0.00% |